OrthoBio Therapeutics is a biotechnology company that offers innovative therapies in pre-clinical in vitro and in vivo studies.
OrthoBio Therapeutics has raised $31.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
OrthoBio Therapeutics is headquartered in Vail, United States.
OrthoBio Therapeutics is a biotechnology company that offers innovative therapies in pre-clinical in vitro and in vivo studies.
OrthoBio Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OrthoBio Therapeutics — Funding & Investors." VCBacked, July 2, 2025, https://www.vcbacked.co/company/orthobio-therapeutics. Accessed August 6, 2026.
VCBacked. (2025). OrthoBio Therapeutics — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/orthobio-therapeutics
{{cite web |title=OrthoBio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orthobio-therapeutics |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated